A Study to Test Different Ways to Measure the Effect of Atomoxetine on Impulsive Behavior in Young Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Clinical trial NCT05278104 · COMPLETED
Trial details
- NCT number
- NCT05278104
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-14
- Primary completion
- 2024-10-23
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.